Tapazole · DIN 02296039 · 10 mg · tablet
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2026-07-16 — choose a marketed DIN from the same-category list.Discontinued July 16, 2026 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2026-07-16 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2026-07-16 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Tapazole · DIN 02296039
Manufacturer: Knight Therapeutics Inc.; listing date 2018-12-21
Health Canada: Cancelled post market since 2026-07-16 · brand TAPAZOLE · ATC H03BB02 THIAMAZOLE · form Tablet · route Oral · ingredients METHIMAZOLE 10 MG · company Knight therapeutics inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTapazole: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02296039)
Source record
DIN 02296039: Tapazole
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 683800004; group id 808; item number 1986; lccId None; manufacturer id KNT
Source form: Tab; strength: 10mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02296039
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=78139
Interchangeable products
Jamp Methimazole · DIN 02490633 · not recorded
Mar-Methimazole · DIN 02480115 · not recorded
Shortage status: active shortage (reported October 30, 2024, last updated November 1, 2024) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02296039
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 16, 2026 — choose a marketed DIN from the same-category list.